Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition.
J Gastrointest Oncol
; 9(4): 610-617, 2018 Aug.
Article
in En
| MEDLINE
| ID: mdl-30151257
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Gastrointest Oncol
Year:
2018
Type:
Article
Affiliation country:
United States